HEALTH

SAN FRANCISCO — Less than 20% of surveyed patients with nasal allergies find their symptoms are completely controlled over a one-week period of treatment, according to a survey performed by drug maker Teva Pharmaceutical Industries.

OAKLAND, Calif. — The Association of Asian Pacific Community Health Organizations has introduced a program that aims to reduce the secondary complications of diabetes among specific ethnic groups living with the disease.

AAPCHO said its five-year diabetes program addresses diabetes among vulnerable populations in three Asian-American, Native Hawaiian and other Pacific Islander communities:

AMITYVILLE, N.Y. — Generic drug maker Hi-Tech Pharmacal has acquired the rights to a drug for mouth infections, the company said Monday.

Hi-Tech said it acquired nystatin oral suspension from Bausch & Lomb for an undisclosed sum. The drug is used to treat candidiasis, a fungal infection, in the mouth.

The market for the drug is $23 million, according to IMS Health.

FT. LAUDERDALE, Fla. — Nipro Diagnostics, a provider of diabetes monitoring and management products, announced the promotion of Gregg Johnson to SVP consumer healthcare and Lisa Nardi to VP marketing. Both will continue reporting to Scott Verner, Nipro president.

WATERTOWN, Mass. — Exergen said a new patent granted to the company protects its temporal artery thermometers brand.

Exergen said its portfolio of intellectual property rights has expanded with the new patent for its TemporalScanner brand of noninvasive thermometry products. Recently, Exergen said it filed a patent infringement suit in the U.S. District Court for the District of Massachusetts against Kidz-Med, American Scientific Resources and Tecnimed SRL.

REDFORD, Mich. — Nature's Health Connection said its over-the-counter pain-relief cream has garnered record retail sales.

Sales for Australian Dream — a Food and Drug Administration-approved odorless, greaseless, dye-free and capsaicin-free cream — increased more than 145%, according to the company. Nature's Health Connection attributed the sales spike to a 30-second television commercial. 

Australian Dream is designed to treat minor aches and pains associated with osteo- and rheumatoid arthritis, as well as other muscle ailments.

MANHATTAN BEACH, Calif. — Shortly after announcing the launch of its weight-loss system for men, Sensa is introducing a fruity lineup of energy-enhanced vitamin drinks.

Sensa Quench, available in orange crush, pink grapefruit and berry splash flavors, is a sugar-free drink mix that when added to 12 oz. of water includes a powerful blend of natural ingredients to energize, help increase the metabolism and hydrate, according to the company.

The Sensa Quench weight-loss system is available in a 30-pack for $39.95.

LONDON — With respect to the Type 2 diabetes drug Avandia, British drug maker GlaxoSmithKline has another medical study to worry about.